CLIENTS/PROJECTS
Svizera Labs Pvt Ltd
Pharmaceuticals – Nov 2016 to Oct 2017
Remediated the Notice of Suspension served by WHO Geneva, with project management and respective documentation.
As part of remediation, carried out a gap assessment and the remediation of the controls in the ERP system and the Computer System validation of the Progen ERP system that was being used.
EID Parry
Nutraceuticals – Jan 2017 to Mar 2019
Gap Analysis and Upgradation of system and procedures as per USFDA Dietary supplements guideline requirements as per CFR 21 Part 111 “Current Good Manufacturing Practices in manufacturing, packaging, holding ,and labelling of Dietary Supplements” and Food safety requirements as per CFR 21 Part 117 “Good Manufacturing Practices , Hazard Analysis, Risk Based Preventive controls for Human Food”.
As part of upgradation, carried out a gap assessment and the remediation of the SAP system (SAP EHP 6.0 ) that was being used for the business process, with respect to the process and the controls available.
Raptakos and Brett
Pharmaceuticals – June 2018 to Sept 2019
Gap Analysis and cGMP systems and Procedures enhancement as per PIC/S Guidelines (PIC/S guide to PE-010-04-Good Practices for the preparation of medicinal products in healthcare establishments requirements)
Fullife Healthcare
Pharmaceuticals – Mar 2019 to Sept 2019
Provided cGMP support and guidance for establishment of an EU GMP Facility
Neopharma -UAE
Pharmaceuticals – Sept 2019
Gap analysis of Quality Control instruments Qualifications, Calibrations and CFR 21 Part 11 assessment.
Gap Analysis of the SAP EHP 8.0 system for end to end business process implementation and controls.
Raptakos and Brett
Pharmaceuticals – Aug 2020 and Ongoing
Implementation of Controlled Issuance of GMP documents from SAP EHP 8.0 with Computer System validation : Status : In-progress
Implementation of Document Management System from SAP EHP 8.0 with Computer System validation : Status : Next Planned
Implementation of Quality Management System from SAP EHP 8.0 with Computer System validation : Status : Next Planned
EID Parry
Sugar Division (Total of 8 plants) – Feb 2021 and Ongoing
Market Complaints Remediation : Investigation, Root cause analysis , Corrective and Preventive actions and remediation of Market complaints : Status : In – Progress
Gap Analysis and Implementation of Food Safety Management System as per ISO 22000 latest version : Status : In – Progress
In Pipeline and under discussions
Establishment of an EU GMP Facility for Sterile Injectables at Jammu
Establishment of an WHO GMP Facility for Sterile Injectables at Palghar
Establishment of a R&D center and a Clinical pilot manufacturing facility for NCE at Shirdi.
Mock USFDA Audit for an API Facility to clear OAI status.
Upgradation of systems and procedures for a Contract testing lab as per USFDA standards.